首页|银杏叶提取物联合低分子肝素预防骨折患者DVT发生的临床疗效分析

银杏叶提取物联合低分子肝素预防骨折患者DVT发生的临床疗效分析

扫码查看
目的 探讨银杏叶提取物联合低分子肝素预防骨折患者深静脉血栓(deep vein thrombosis,DVT)发生的临床疗效.方法 选择2021 年12 月~2023 年 12 月就诊于我院的 500 例下肢骨折患者,将患者随机分为治疗组和对照组,每组250 例,对照组采取低分子肝素钠常规抗凝治疗,治疗组在常规抗凝治疗基础上加用银杏叶提取物(舒血宁注射液),观察两组患者DVT发生率、凝血指标变化、不良反应发生情况.结果 治疗组DVT总发生率为13.6%,与对照组(19.6%)比较,差异有统计学意义(P<0.05);其中各亚组中治疗组与对照组比较股骨髁上、髁间骨折(22%vs 28%),股骨干骨折(12%vs 18%),髋部骨折(11.3%vs 17.3%),差异均具有统计学意义;入院后抗凝前活化部分凝血活酶时间(activated partial thromboplastin time,APTT)、凝血酶原时间(prothrombin time,PT)、凝血酶时间(thrombin time,TT)、纤维蛋白原含量(fibrinogen,Fg)、D-二聚体(D-Dimer)在治疗组和对照组间均无统计学差异(P>0.05);术后凝血常规中PT、Fg、D-Dimer治疗组和对照组之间差异均具有统计学意义(P<0.05),两组间APTT、TT差异无统计学意义(P>0.05);APTT、Fg、D-Dimer在血栓组和无血栓组之间差异均具有统计学意义(P<0.05),两组间PT、TT差异无统计学意义(P>0.05);两组患者均无明显不良反应发生.结论 银杏叶提取物联合低分子肝素可以有效降低DVT高发部位骨折的DVT发生率,且不增加并发症的发生,临床疗效显著,可作为今后临床对DVT高发部位骨折DVT预防的有效策略.
Clinical efficacy analysis of Ginkgo biloba leaf extract combined with low molecular weight heparin in preventing DVT in fracture patients
Objective To explore the clinical efficacy of Ginkgo biloba leaf extract combined with low molecular weight heparin in preventing deep vein thrombosis(DVT)in patients with fractures.Methods Five hundred patients with lower limb fractures who visited our hospital from December 2021 to December 2023 were selected and randomly divided into treatment group and control group,with 250 cases in each group.The control group received convention-al anticoagulation treatment with low molecular weight heparin sodium,while the treatment group received Ginkgo biloba leaf extract(Shuxuening injection)in addition to conventional anticoagulation treatment.The incidence of DVT,changes in coagulation indicators,and inci-dence of adverse reactions were observed in both groups of patients.Results The total inci-dence of DVT in the treatment group was 13.6%,which was statistically significant compared with the control group of 19.6%(P<0.05);In each subgroup,the treatment group showed statistically significant differences in femoral condylar and intercondylar fractures(22%vs 28%),femoral shaft fractures(12%vs 18%),and hip fractures(11.3%vs 17.3%)com-pared with the control group;After admission,there was no statistically significant difference in activated partial thromboplastin time(APTT),prothrombin time(PT),thrombin time(TT),fi-brinogen content(Fg),and D-dimer(D-Dimer)between the treatment group and the control group(P>0.05);The differences in postoperative coagulation routine between the PT,Fg,D-Dimer between treatment group and the control group were statistically significant(P<0.05),while there was no statistically significant difference in APTT and TT between the two groups(P>0.05);The differences in APTT,Fg,and D-Dimer between the thrombotic and non thrombotic groups were statistically significant(P<0.05),while there was no statistically significant difference in PT and TT between the two groups(P>0.05);Both groups of pa-tients had no significant adverse reactions.Conclusion Ginkgo biloba leaf extract combined with low molecular weight heparin can effectively reduce the incidence of DVT in high inci-dence site fractures without increasing the incidence of complications.The clinical efficacy is significant and can be used as an effective strategy for preventing DVT in high incidence site fractures in future clinical practice.

deep vein thrombosisGinkgo biloba leaf extractlow molecular weight heparinfracture

臧加成、马信龙、杨爽、于树军、李辰、张银光

展开 >

天津大学天津医院,天津市天津医院 髋关节一病区,天津 300211

深静脉血栓 银杏叶提取物 低分子肝素 骨折

天津市卫生健康委天津市中医药管理局中医中西医结合科研课题

2021157

2024

哈尔滨医科大学学报
哈尔滨医科大学

哈尔滨医科大学学报

CSTPCD
影响因子:1.117
ISSN:1000-1905
年,卷(期):2024.58(4)